Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-22-002372
Filing Date
2022-02-17
Accepted
2022-02-17 06:00:56
Documents
1
Period of Report
2022-02-14

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 11239
  Complete submission text file 0001225208-22-002372.txt   12560
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Issuer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0102
SIC: 2834 Pharmaceutical Preparations

Mailing Address THERAVANCE,INC. 901 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Mammen Mathai (Reporting) CIK: 0001421050 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-03215 | Film No.: 22645513